Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
By Federica Zatterale, M. Longo, Jamal Naderi, G. A. Raciti, Antonella Desiderio, C. Miele, F. Beguinot. Frontiers in Physiology, 2020
986 citations recorded by the source corpus.
Obesity is one of the major health burdens of the 21st century as it contributes to the growing prevalence of its related comorbidities, including insulin resistance and type 2 diabetes. Growing evidence suggests a critical role for overnutrition in the development of low-grade inflammation. Specifically, chronic inflammation in adipose tissue is considered a crucial risk factor for the development of insulin resistance and type 2 diabetes in obese individuals. The triggers for adipose tissue inflammation are still poorly defined. However, obesity-induced adipose tissue expansion provides a plethora of intrinsic signals (e.g., adipocyte death, hypoxia, and mechanical stress) capable of initiating the inflammatory response. Immune dysregulation in adipose tissue of obese subjects results in a chronic low-grade inflammation characterized by increased infiltration and activation of innate and adaptive immune cells. Macrophages are the most abundant innate immune cells infiltrating and accumulating into adipose tissue of obese individuals; they constitute up to 40% of all adipose tissue cells in obesity. In obesity, adipose tissue macrophages are polarized into pro-inflammatory M1 macrophages and secrete many pro-inflammatory cytokines capable of impairing insulin signaling, therefore promoting the progression of insulin resistance. Besides macrophages, many other immune cells (e.g., dendritic cells, mast cells, neutrophils, B cells, and T cells) reside in adipose tissue during obesity, playing a key role in the development of adipose tissue inflammation and insulin resistance. The association of obesity, adipose tissue inflammation, and metabolic diseases makes inflammatory pathways an appealing target for the treatment of obesity-related metabolic complications. In this review, we summarize the molecular mechanisms responsible for the obesity-induced adipose tissue inflammation and progression toward obesity-associated comorbidities and highlight the current therapeutic strategies.
Subfields: Epidemiology, Immunology, Physiology
View Paper: https://www.semanticscholar.org/paper/173b6fcaa2564eb5f3569c9caa3aa332e520095a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Physiology
- Alexander Sakers
- Dan Xiao
- Weifeng Zhang
- Mirian Krystel De Siqueira
- Haibin Xia
- Q. Mao
- P. Seale
- Claudio J. Villanueva
Citations in the corpus
- Adipose tissue plasticity in health and disease (2022, background): “Chronic inflammation is believed to be a major contributor to the impairment in the metabolic plasticity of fat (Zatterale et al., 2019).”
- Role of neuroinflammation in neurodegeneration development (2023, background): “Obesity was found to be associated with a state of chronic, low-grade systemic inflammation.(105) In obese patients, dysregulated lipid metabolism leads to increased levels of free fatty acids in circulation, which can bind to PRRs on immune cells and induce the release of proinflammatory cytokines,”